GlassScriptPhysician profile
Kaitlin Kaus
NPI 1053951202
$702.73
in general payments reported to CMS, 2019-2025
17 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.59 · 2023: $151 · 2024: $287 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $114.92 | 2024 | |
| Foundation Fusion Solutions, LLC | $97.00 | 2025 | |
| Nevro Corp. | $75.96 | 2024 | Senza |
| Sanara Medtech INC. | $58.56 | 2023 | Celleraterx |
| Mdd US Operations, LLC | $42.70 | 2023 | Apokyn |
| Ucb, INC. | $39.18 | 2025 | Zilbrysq |
| Vertex Pharmaceuticals Incorporated | $33.02 | 2025 | |
| Neurocrine Biosciences, INC. | $29.25 | 2024 | Ingrezza |
| Si-Bone, INC. | $27.02 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $26.91 | 2023 | Rexulti |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $24.81 | 2025 | |
| Medtronic, INC. | $24.05 | 2022 | |
| Collegium Pharmaceutical, INC. | $23.54 | 2022 | |
| Biogen, INC. | $22.87 | 2025 | Tysabri, Vumerity |
| Alnylam Pharmaceuticals INC. | $22.60 | 2023 | Onpattro |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20.61 | 2024 | Kisunla |
| Banner Life Sciences, LLC | $19.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Kaus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.